The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
Open accessAbstract
BACKGROUND: The COVID-19 pandemic could lead to disruptions to provision of HIV services for people living with HIV and those at risk of acquiring HIV in sub-Saharan Africa, where UNAIDS estimated that more than two-thirds of the approximately 38 million people living with HIV resided in 2018. We aimed to predict the potential effects of such disruptions on HIV-related deaths and new infections in sub-Saharan Africa. METHODS: In this modelling study, we used five well described models of HIV epidemics (Goals, Optima HIV, HIV Synthesis, an Imperial College London model, and Epidemiological MODeling software [EMOD]) to estimate the effect of various potential disruptions to HIV prevention, testing, and treatment services on HIV-related deaths and new infections in sub-Saharan Africa lasting 6 months over 1 year from April 1, 2020. We considered scenarios in which disruptions affected 20%, 50%, and 100% of the population. FINDINGS: A 6-month interruption of supply of antiretroviral therapy (ART) drugs across 50% of the population of people living with HIV who are on treatment would be expected to lead to a 1·63 times (median across models; range 1·39-1·87) increase in HIV-related deaths over a 1-year period compared with no disruption. In sub-Saharan Africa, this increase amounts to a median excess of HIV deaths, across all model estimates, of 296 000 (range 229 023-420 000) if such a high level of disruption occurred. Interruption of ART would increase mother-to-child transmission of HIV by approximately 1·6 times. Although an interruption in the supply of ART drugs would have the largest impact of any potential disruptions, effects of poorer clinical care due to overstretched health facilities, interruptions of supply of other drugs such as co-trimoxazole, and suspension of HIV testing would all have a substantial effect on population-level mortality (up to a 1·06 times increase in HIV-related deaths over a 1-year period due to disruptions affecting 50% of the population compared with no disruption). Interruption to condom supplies and peer education would make populations more susceptible to increases in HIV incidence, although physical distancing measures could lead to reductions in risky sexual behaviour (up to 1·19 times increase in new HIV infections over a 1-year period if 50% of people are affected). INTERPRETATION: During the COVID-19 pandemic, the primary priority for governments, donors, suppliers, and communities should focus on maintaining uninterrupted supply of ART drugs for people with HIV to avoid additional HIV-related deaths. The provision of other HIV prevention measures is also important to prevent any increase in HIV incidence. FUNDING: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hogan, A. B., Jewell, B. L., Sherrard-Smith, E., Vesga, J. F., Watson, O. J., Whittaker, C., Hamlet, A., Smith, J. A., Winskill, P., Verity, R., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30288-6 · Cited by 900
Self-citationYoung, S., Wheeler, A. C., McCoy, S. I., & Weiser, S. D. (2014) · AIDS and Behavior · doi:10.1007/s10461-013-0547-4 · Cited by 263
Stover, J., Bollinger, L., Izazola, J. A., Loures, L., DeLay, P., Ghys, P. D., & Fast Track modeling working group (2016) · PLOS ONE · doi:10.1371/journal.pone.0154893 · Cited by 229
Self-citationAfrica in the Path of Covid-19
El-Sadr, W. M., & Justman, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2008193 · Cited by 197
Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020
Glaziou, P. (2020) · medRxiv · doi:10.1101/2020.04.28.20079582 · Cited by 162
Implementation and applications of EMOD, an individual-based multi-disease modeling platform
Bershteyn, A., Gerardin, J., Bridenbecker, D., Lorton, C., Bloedow, J., Baker, R. S., Chabot‐Couture, G., Chen, Y., Fischle, T., Frey, K., et al. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty059 · Cited by 111
Self-citationOptima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization
Kerr, C. C., Stuart, R. M., Gray, R. T., Shattock, A. J., Fraser‐Hurt, N., Benedikt, C. J., Haacker, M., Berdnikov, M., Mahmood, A. M., Jaber, S. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000605 · Cited by 109
Mutasa‐Apollo, T., Ford, N. P., Wiens, M. O., Socias, M. E., Negussie, E. K., Wu, P., Popoff, E., Park, J., Mills, E. J., & Kanters, S. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.5.21647 · Cited by 69
Impact and Programmatic Implications of Routine Viral Load Monitoring in Swaziland
Jobanputra, K., Parker, L. A., Azih, C., Okello, V., Maphalala, G. P., Jouquet, G., Kerschberger, B., Mekeidje, C., Cyr, J., Mafikudze, A., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000224 · Cited by 51
Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014
Leuenberger, D., Hébélamou, J., Strahm, S., de Rekeneire, N., Balestre, É., Wandeler, G., & Dabis, F. (2015) · AIDS · doi:10.1097/qad.0000000000000784 · Cited by 43
Cited by
Dorward, J., Khubone, T., Gate, K., Ngobese, H., Sookrajh, Y., Mkhize, S., Jeewa, A., Bottomley, C., Lewis, L., Baisley, K., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(20)30359-3 · Cited by 300
Santos, G.-M., Ackerman, B., Rao, A., Wallach, S., Ayala, G., Lamontage, E., Garner, A., Holloway, I. W., Arreola, S., Silenzio, V., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-020-02969-0 · Cited by 253
Grimsrud, A., & Wilkinson, L. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25704 · Cited by 104
Nachega, J. B., Kapata, N., Sam-Agudu, N. A., Decloedt, E. H., Katoto, P. D. M. C., Nagu, T., Mwaba, P., Yeboah-Manu, D., Chanda-Kapata, P., Ntoumi, F., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.038 · Cited by 80
Achieving global mortality reduction targets and universal health coverage: the impact of COVID-19
Mao, W., Ogbuoji, O., Watkins, D., Bharali, I., Nsiah-Boateng, E., Diab, M. M., Dwomoh, D., Jamison, D. T., Kumar, P., Kennedy McDade, K., et al. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003675 · Cited by 18
Metadata
- Authors
- Jewell, B. L., Mudimu, E., Stover, J., ten Brink, D., Phillips, A. N., Smith, J. A., Martin-Hughes, R., Teng, Y., Glaubius, R., Mahiane, S. G., Bansi-Matharu, L., Taramusi, I., Chagoma, N., Morrison, M., Doherty, M., Marsh, K., Bershteyn, A., Hallett, T. B., & Kelly, S. L.
- Venue
- The Lancet HIV
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 7
- Issue
- 9
- Pages
- e629-e640
- ISSN
- 2352-3018 (ISSN-L)
- OpenAlex
- W3047456007
- Cited by
- 401
- References
- 14
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. https://app.cochat.ai/papers/10.1016/s2352-3018(20)30211-3
- The paper
- Jewell, B. L., Mudimu, E., Stover, J., ten Brink, D., Phillips, A. N., Smith, J. A., Martin-Hughes, R., Teng, Y., Glaubius, R., Mahiane, S. G., Bansi-Matharu, L., Taramusi, I., Chagoma, N., Morrison, M., Doherty, M., Marsh, K., Bershteyn, A., Hallett, T. B., & Kelly, S. L. (2020). Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. The Lancet HIV. https://doi.org/10.1016/s2352-3018(20)30211-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.